Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Zuck TF. An hypothesis on the cost effectiveness of homologous blood transfusions in 1988. Transfus Med Rev 1988;2:245-9. [PMID: 2980092 DOI: 10.1016/s0887-7963(88)70052-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]

For:	Zuck TF. An hypothesis on the cost effectiveness of homologous blood transfusions in 1988. Transfus Med Rev 1988;2:245-9. [PMID: 2980092 DOI: 10.1016/s0887-7963(88)70052-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]

Number	Cited by Other Article(s)
1	Carter TH. Biotechnology, economics, and the business of blood. BIOTECHNOLOGY (READING, MASS.) 1991;19:3-30. [PMID: 1786473 DOI: 10.1016/b978-0-7506-9120-8.50006-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Abstract Collapse Key Words Collapse MESH Headings Biotechnology Blood Banks/economics Blood Banks/organization & administration Blood Banks/statistics & numerical data Blood Banks/supply & distribution Blood Component Removal/economics Blood Component Removal/methods Blood Component Transfusion/economics Blood Component Transfusion/methods Blood Donors Blood Substitutes Blood Transfusion/economics Blood Transfusion/methods Blood Transfusion/statistics & numerical data Blood Transfusion, Autologous/methods Costs and Cost Analysis Erythropoiesis/drug effects Erythropoietin/pharmacology Europe Genetic Engineering Humans Japan Plasma Red Cross United States Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Carter TH. Biotechnology, economics, and the business of blood. BIOTECHNOLOGY (READING, MASS.) 1991;19:3-30. [PMID: 1786473 DOI: 10.1016/b978-0-7506-9120-8.50006-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]